Moreover, FABP4 and FABP5—known to be regularly expressed during adipocyte differentiation—have been found at high levels in cancers of the prostate, breast, and ovaries, where they promote malignant progression and metastasis and worsen prognosis [14,55,56,57,58,59]. This evidence concerns the gene FABP4 and cancer.